BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 32166986)

  • 1. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
    Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
    J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
    Su D; Ji Z; Xue P; Guo S; Jia Q; Sun H
    Cancer Manag Res; 2020; 12():6317-6329. PubMed ID: 32848452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
    Yin W; Shi L; Mao Y
    J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
    Zhang H; Li M; Zhang J; Shen Y; Gui Q
    Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
    Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
    FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.
    Wu Y; Huang J; Xu H; Gong Z
    Biomed Pharmacother; 2018 Sep; 105():1325-1334. PubMed ID: 30021370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
    J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
    Zhang D; Yang XJ; Luo QD; Xue L; Chong T
    Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.
    Zhang ML; Sun WH; Wu HQ; Liu ZD; Wang P
    Neoplasma; 2020 Nov; 67(6):1266-1278. PubMed ID: 32749848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
    Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H; Huhe M; Lou J
    Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.
    Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S
    Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of miR-103a-3p Targeted Regulation of TRIM66 Axis on Docetaxel Resistance and Glycolysis in Prostate Cancer Cells.
    Yi Q; Wei J; Li Y
    Front Genet; 2021; 12():813793. PubMed ID: 35211152
    [No Abstract]   [Full Text] [Related]  

  • 16. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7
    Hu X; Miao J; Zhang M; Wang X; Wang Z; Han J; Tong D; Huang C
    Mol Cells; 2018 May; 41(5):390-400. PubMed ID: 29754469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MEG3 promotes endoplasmic reticulum stress and suppresses proliferation and invasion of colorectal carcinoma cells through the MEG3/miR-103a-3p/PDHB ceRNA pathway.
    Wang G; Ye Q; Ning S; Yang Z; Chen Y; Zhang L; Huang Y; Xie F; Cheng X; Chi J; Lei Y; Guo R; Han J
    Neoplasma; 2021 Mar; 68(2):362-374. PubMed ID: 33118833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
    Liu J; Quan Z; Gao Y; Wu X; Zheng Y
    Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIR503HG Overexpression Inhibits the Malignant Behaviors of Osteosarcoma Cells by Sponging miR-103a-3p.
    Li E; Zhong S; Ma G; Wang Q; Gao Y
    Crit Rev Eukaryot Gene Expr; 2023; 33(3):1-11. PubMed ID: 37017665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.